Last updated 2026-07-20
- Raised $1M Series A led by PipelBiz, Mar 2024
- Raised Seed round led by Lonza, Jun 2021
Total raised
$1.0M
Last: Undisclosed Round 2024-04
Stage
Seed
Founded
2019
Headcount
6
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
NOGA Therapeutics is a pioneering gene therapy company that leverages lentiviral vector technology to develop targeted, transformative therapies for severe and chronic illnesses. Their mission is to create life-changing gene therapies that provide durable, precise, and safe solutions, aiming to eliminate suffering for patients with rare and severe diseases worldwide. They focus on engineering hematopoietic stem cells to deliver biological therapies, including solutions for diseases like X-linked Agammaglobulinemia (XLA) and Parkinson's disease. The company's platform technology uses lentiviral-based vectors to genetically reprogram blood stem cells. NOGA Therapeutics is developing therapies for both rare and common diseases.
Funding history · 2 rounds · $1.0M total
2024-03
A Round
$1.0M
★ PipelBiz
2021-06
Seed
Undisclosed
★ Lonza
Headcount over time
From 5 (2024-01) to 7 (2026-03) · +2 (+40%) · 6 points · source: Finder history + radar grounding
Q&A
- What is NOGA Therapeutics' primary focus?
- NOGA Therapeutics is a gene therapy company focused on blood stem cell reprogramming to create transformative treatments for patients with severe and chronic illnesses.
- When was NOGA Therapeutics founded?
- NOGA Therapeutics was founded in January 2020.
- How many employees does NOGA Therapeutics have?
- NOGA Therapeutics has 1-10 employees.
- What is NOGA Therapeutics' total funding to date?
- NOGA Therapeutics has raised a total of $1,000,000 USD.
- Which investor participated in NOGA Therapeutics' funding round in April 2024?
- PipelBiz participated in NOGA Therapeutics' funding round in April 2024, which raised $1,000,000 USD.
- What is a key therapeutic area for NOGA Therapeutics?
- NOGA Therapeutics' therapeutic pipeline includes DopaGene for Parkinson’s disease, a gene therapy designed to induce sustained dopamine production in the brain.
- What technology does NOGA Therapeutics utilize for its gene therapies?
- NOGA Therapeutics utilizes advanced lentiviral vector technology to reprogram blood stem cells.
- Who is a co-founder and COO of NOGA Therapeutics?
- Noam Baumatz is a Co-founder and COO of NOGA Therapeutics.
Team · 3
Noam Baumatz
Founder · Co-founder & CEO
Noam C. Diamant
Founder · Co-founder & President
Liron Elkouby
Founder · Scientific Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
chronic-diseasestem-cellsrare-diseasesparkinsonpharmaceuticalsimmunotherapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | noga-tx.com/ |
|---|---|
| linkedin.com/company/51679771 |
Identifiers & details
| Founded | 2019 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | noga-tx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516047784 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-06-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 5 — people (2), shares_capital (2), other (1) |
| Registered address | ספיר פנחס 3 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2025-10-30 | עדכון דירקטורים-הסרת דירקטור |
| 2025-11-20 | הקצאת מניות |
| 2025-08-10 | שינוי בהרכב הון - מניות-פיצול מניה |
| 2025-08-10 | שינוי בתקנון |
| 2025-08-04 | עדכון בעלי תפקידים |